Oxyphenbutazone
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384609This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H806S4B3NS, chemically known as 3,5-pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (van) (8ci) but generally known as oxyphenbutazone, which bears US NIH Compound Identifier 4641. European Medicines Agency schedules Oxyphenbutazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09572MIG. World Health Organization schedules oxyphenbutazone in its Anatomical Therapeutic Chemical (ATC) Classification. OXYPHENBUTAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxyphenbutazone under HS 29331990 and SITC 51571. As of Q4 2014, OXYPHENBUTAZONE remains the US FDA Preferred Term for this commodity. Oxyphenbutazone bears US NLM identifiers UMLS ID C0030078 and NCI Concept Code C66282. SMILES: O=C1N(N(C(=O)C1CCCC)C1CCCCC1)C1CCC(O)CC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.